Literature DB >> 7542560

Alterations of cell surface antigens induced by placental isoform of ferritin in human carcinoma cell lines.

J Sedlak1, M Reinerova, L Hunakova, C Ausch, B Chorvath, H Rosen, C Moroz.   

Abstract

AIM: the ability of the breast cancer-associated placental acid isoform of ferritin (p43-PLF) to modulate cell surface expression of HLA, CD59 (protectin) and CD66 antigen (adhesion antigen related to CEA) was examined.
METHODS: the expression of these antigens in human breast carcinoma cell lines BT-20, T47D and MDA-MB-468 was determined with the aid of flow cytometry and monoclonal antibodies.
RESULTS: PLF induced a transient up-regulation followed by a down regulation of cell surface protectin (CD59 antigen) on the cell surface of T47D and to a lesser extent, BT-20 human breast carcinoma cell lines. Furthermore, PLF down-regulated cell surface expression of CEA-related CD66 antigen on both these cell lines. No PLF-induced alterations of protectin, CD66 antigen and HLA class I antigen were found on the MDA-MB-468 breast cancer cell line.
CONCLUSIONS: breast cancer-associated p43 induces alterations of the expression of cell surface molecules in breast cancer cells which could have an effect on the modulation of cancer cell adhesive interactions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7542560     DOI: 10.1016/0304-3835(95)03831-g

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  3 in total

1.  Immunosuppression by breast cancer associated p43-effect of immunomodulators.

Authors:  H R Rosen; C Ausch; G Reiner; M Reinerova; J Svec; H Tüchler; R Schiessel; C Moroz
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

2.  The expression of PLF in placenta in pregnancy-induced hypertension and the relationship between the PLF and serum VCAM-1.

Authors:  Xiaoyan Xu; Wenpei Xiang; Hanping Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2003

3.  Identification of women with early breast cancer by analysis of p43-positive lymphocytes.

Authors:  L Auerbach; M Hellan; M Stierer; A C Rosen; C Ausch; R Obwegeser; E Kubista; G Wolf; H R Rosen; S Panzer
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.